Skip to Content

Join the 'Pyrazinamide' group to help and get support from people like you.

Pyrazinamide News

Global Efforts to Combat TB Epidemic Falling Short

Posted 13 Oct 2016 by Drugs.com

THURSDAY, Oct. 13, 2016 – Countries around the world need to work harder to combat tuberculosis infections and deaths, a new World Health Organization report says. Nations across the globe have pledged to reduce tuberculosis (TB) infections by 80 percent and TB deaths by 90 percent by 2030, but they must work faster if they want to meet these goals, according to the WHO. "We face an uphill battle to reach the global targets for tuberculosis," WHO Director General Dr. Margaret Chan said in an organization news release. "There must be a massive scale-up of efforts, or countries will continue to run behind this deadly epidemic and these ambitious goals will be missed." Tuberculosis is a disease that mainly affects the lungs. The bacteria that cause TB are primarily spread from person to person through tiny droplets from coughs and sneezes. The global response to the TB epidemic did manage ... Read more

Related support groups: Tuberculosis, Rifampin, Tuberculosis - Latent, Tuberculosis - Active, Ethambutol, Pulmonary Tuberculosis, Tuberculosis - Prophylaxis, Pyrazinamide, Diagnosis and Investigation, Tuberculosis - Extrapulmonary, Isoniazid/Rifampin, Rifabutin, Rifamate, Rifater, Tuberculosis - Resistant, Mycobutin, Rifadin, Tuberculosis - HIV Negative, Tuberculosis - HIV Status Unknown, Tuberculous Meningitis

E-Pillboxes Improve Medication Adherence, Study Finds

Posted 15 Sep 2015 by Drugs.com

TUESDAY, Sept. 15, 2015 – Electronic reminders may help people with tuberculosis take their medication properly, a new study suggests. Tuberculosis (TB) patients are less likely to miss doses when they receive alerts from an electronic pillbox, researchers report in the Sept. 15 issue of PLOS Medicine. Electronic pillboxes use visual, audio and/or vibration cues to signal when it's time to take medication. TB is a bacterial infection that mainly strikes the lungs. The traditional method of ensuring medical adherence in TB patients is to watch people take their medicine, but the study authors said this isn't doable in remote areas such as rural China. "Innovative approaches to enable patients to adhere to TB treatment are needed. Widespread use of medication monitors in national TB control programs can benefit from the development of a low-cost and reliable medication monitor as well as ... Read more

Related support groups: Tuberculosis, Isoniazid, Rifampin, Tuberculosis - Active, Ethambutol, Pulmonary Tuberculosis, Tuberculosis - Prophylaxis, Pyrazinamide, Tuberculosis - Extrapulmonary, Rifamate, Isoniazid/Rifampin, Rifabutin, Rifadin, Mycobutin, Rifater, Myambutol, Nydrazid, IsonaRif, Rimactane, Priftin

TB Outbreaks in Texas Schools Show Disease Still a Threat

Posted 14 Oct 2011 by Drugs.com

FRIDAY, Oct. 14 – Outbreaks among young people in Texas of the old foe tuberculosis – often mistakenly dismissed as a long-ago health menace now confined to the pages of a Charles Dickens novel – show that the respiratory disease is still easily contracted and remains a potential threat to Americans, experts say. "Tuberculosis has always been with us and probably always will be," said Dr. Len Horovitz, a pulmonary specialist with Lenox Hill Hospital in New York City. At least 100 people have tested positive for tuberculosis (TB) on skin tests in Ennis, Texas, about 40 miles south of Dallas, including several students at the local high school. The testing was done after a teacher was diagnosed with TB before the start of the school year. And the University of North Texas in Denton – about 70 miles away – recommended that 27 people who had had contact with a student diagnosed with a ... Read more

Related support groups: Tuberculosis, Isoniazid, Rifampin, Ethambutol, Pyrazinamide, Myambutol, Rifadin, Rifadin IV, Rimactane, Nydrazid

FDA Medwatch Alert: Rifampin plus Pyrazinamide for Treatment of Latent Tuberculosis Infection (LTBI)

Posted 12 Aug 2003 by Drugs.com

The Centers for Disease Control and Prevention (CDC) notified healthcare professionals of revised recommendations against the use of rifampin plus pyrazinamide for treatment of latent tuberculosis infection, due to high rates of hospitalization and death from liver injury associated with the combined use of these drugs.[August 8, 2003 Letter - CDC][August 8, 2003 MMWR Article - CDC] Read more

Related support groups: Pyrazinamide, Rifadin

Ask a Question

Further Information

Related Condition Support Groups

Tuberculosis - Active, Tuberculosis - Latent

Pyrazinamide Patient Information at Drugs.com